Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2015

View Archived Issues

Modified cobratoxin RPI-78M granted U.S. orphan status for pediatric multiple sclerosis

Ex scientia delivers first compound in Sumitomo Dainippon collaboration

Incyte and Jiangsu Hengrui Medicine sign global license agreement for SHR-120

Novimmune and Baxalta form collaboration to discover bispecific antibodies

Redx and Horizon Discovery establish cancer research collaboration

Department of Defense awards Cleveland BioLabs contract for development of entolimod

Prostate tissue accumulation inconsistent with absorption-enhanced formulation of DIM

Dose-response effects described for encenicline in schizophrenia

Patupilone active against brain metastases from non-small cell lung cancer

Cellsight Technologies PET tracer [18F]F-AraG first-in-human results are positive

FORUM Pharmaceuticals describes PDE9A inhibitors that may improve cognition

Daiichi Sankyo discloses RuvB-like 1/RuvB-like 2 complex ATPase inhibitors

Bionomics presents new VEGFR-3/FAK inhibitors

Novartis' Farydak receives E.U. approval for multiple myeloma

Achillion discovers complement factor D inhibitors

Boehringer Ingelheim discloses neutrophil elastase inhibitors

Bristol-Myers Squibb introduces HIV integrase inhibitors

FDA extends PDUFA date for Kanuma

Relief Therapeutics licenses atexakin alfa rights from Merck Serono

FDA grants priority review to daratumumab BLA for multiple myeloma

Allergan to acquire ocular device company AqueSys

FDA approves Xuriden for hereditary orotic aciduria

Terumo's autologous skeletal myoblast sheets approved in Japan for heart failure

Audentes Therapeutics acquires Cardiogen Sciences

Glenmark completes phase I studies for GBR-830

Exploratory trial of SAGE-547 in essential tremor shows significant reduction in tremor

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...